Ligneous periodontitis exacerbated by Behçet's disease in a patient with plasminogen deficiency and a stop-gained variant PLG c.1468C > T: a case report.
Behçet's disease
Gingival hyperplasia
Ligneous periodontitis
PLG
Plasminogen deficiency
Journal
BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684
Informations de publication
Date de publication:
08 11 2023
08 11 2023
Historique:
received:
25
09
2023
accepted:
27
10
2023
medline:
10
11
2023
pubmed:
9
11
2023
entrez:
8
11
2023
Statut:
epublish
Résumé
Plasminogen serves as the precursor to plasmin, an essential element in the fibrinolytic process, and is synthesized primarily in the liver. Plasminogen activation occurs through the action of plasminogen activator, converting it into plasmin. This conversion greatly enhances the fibrinolytic system within tissues and blood vessels, facilitating the dissolution of fibrin clots. Consequently, congenital deficiency of plasminogen results in impaired fibrin degradation. Patients with plasminogen deficiency typically exhibit fibrin deposits in various mucosal sites throughout the body, including the oral cavity, eyes, vagina, and digestive organs. Behcet's disease is a chronic recurrent systemic inflammatory disease with four main symptoms: aphthous ulcers of the oral mucosa, vulvar ulcers, skin symptoms, and eye symptoms, and has been reported worldwide. This disease is highly prevalent around the Silk Road from the Mediterranean to East Asia. We report a case of periodontitis in a patient with these two rare diseases that worsened quickly, leading to alveolar bone destruction. Genetic testing revealed a novel variant characterized by a stop-gain mutation, which may be a previously unidentified etiologic gene associated with decreased plasminogen activity. This case report depicts a patient diagnosed with ligneous gingivitis during childhood, originating from plasminogen deficiency and progressing to periodontitis. Genetic testing revealed a suspected association with the PLG c.1468C > T (p.Arg490*) stop-gain mutation. The patient's periodontal condition remained stable with brief intervals of supportive periodontal therapy. However, the emergence of Behçet's disease induced acute systemic inflammation, necessitating hospitalization and treatment with steroids. During hospitalization, the dental approach focused on maintaining oral hygiene and alleviating contact-related pain. The patient's overall health improved with inpatient care and the periodontal tissues deteriorated. Collaborative efforts between medical and dental professionals are paramount in comprehensively evaluating and treating patients with intricate complications from rare diseases. Furthermore, the PLG c.1468C > T (p.Arg490*) stop-gain mutation could contribute to the association between plasminogen deficiency and related conditions.
Sections du résumé
BACKGROUND
Plasminogen serves as the precursor to plasmin, an essential element in the fibrinolytic process, and is synthesized primarily in the liver. Plasminogen activation occurs through the action of plasminogen activator, converting it into plasmin. This conversion greatly enhances the fibrinolytic system within tissues and blood vessels, facilitating the dissolution of fibrin clots. Consequently, congenital deficiency of plasminogen results in impaired fibrin degradation. Patients with plasminogen deficiency typically exhibit fibrin deposits in various mucosal sites throughout the body, including the oral cavity, eyes, vagina, and digestive organs. Behcet's disease is a chronic recurrent systemic inflammatory disease with four main symptoms: aphthous ulcers of the oral mucosa, vulvar ulcers, skin symptoms, and eye symptoms, and has been reported worldwide. This disease is highly prevalent around the Silk Road from the Mediterranean to East Asia. We report a case of periodontitis in a patient with these two rare diseases that worsened quickly, leading to alveolar bone destruction. Genetic testing revealed a novel variant characterized by a stop-gain mutation, which may be a previously unidentified etiologic gene associated with decreased plasminogen activity.
CASE PRESENTATION
This case report depicts a patient diagnosed with ligneous gingivitis during childhood, originating from plasminogen deficiency and progressing to periodontitis. Genetic testing revealed a suspected association with the PLG c.1468C > T (p.Arg490*) stop-gain mutation. The patient's periodontal condition remained stable with brief intervals of supportive periodontal therapy. However, the emergence of Behçet's disease induced acute systemic inflammation, necessitating hospitalization and treatment with steroids. During hospitalization, the dental approach focused on maintaining oral hygiene and alleviating contact-related pain. The patient's overall health improved with inpatient care and the periodontal tissues deteriorated.
CONCLUSIONS
Collaborative efforts between medical and dental professionals are paramount in comprehensively evaluating and treating patients with intricate complications from rare diseases. Furthermore, the PLG c.1468C > T (p.Arg490*) stop-gain mutation could contribute to the association between plasminogen deficiency and related conditions.
Identifiants
pubmed: 37940896
doi: 10.1186/s12903-023-03586-8
pii: 10.1186/s12903-023-03586-8
pmc: PMC10633900
doi:
Substances chimiques
Fibrinolysin
EC 3.4.21.7
Plasminogen
9001-91-6
Fibrin
9001-31-4
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
843Informations de copyright
© 2023. The Author(s).
Références
Semin Arthritis Rheum. 2022 Feb;52:151956
pubmed: 35038644
Community Dent Oral Epidemiol. 2023 Oct;51(5):705-717
pubmed: 36377800
J Gastroenterol Hepatol. 2022 Apr;37(4):608-619
pubmed: 34894004
Rheumatol Adv Pract. 2022 Aug 17;6(2):rkac061
pubmed: 35993013
N Engl J Med. 1999 Oct 21;341(17):1284-91
pubmed: 10528040
Haematologica. 2020 Mar;105(3):554-561
pubmed: 32001536
Microbiol Immunol. 1995;39(9):729-32
pubmed: 8577288
J Clin Periodontol. 2018 Jun;45 Suppl 20:S219-S229
pubmed: 29926500
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Mar;91(3):334-7
pubmed: 11250632
Arthritis Rheum. 2003 Feb;48(2):319-24
pubmed: 12571839
J Dig Dis. 2018 Jun;19(6):350-358
pubmed: 29851304
Int J Mol Sci. 2021 Dec 29;23(1):
pubmed: 35008762
Int Immunopharmacol. 2023 Sep;122:110524
pubmed: 37393839
Clin Case Rep. 2014 Dec;2(6):274-80
pubmed: 25548630
J Clin Periodontol. 2018 Jun;45 Suppl 20:S171-S189
pubmed: 29926486
Science. 2021 Dec 24;374(6575):1559-1560
pubmed: 34941413
Am J Pathol. 2011 Aug;179(2):819-28
pubmed: 21704601
Orphanet J Rare Dis. 2012 Apr 12;7:20
pubmed: 22497990
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Sep;130(3):e87-e95
pubmed: 32173395
Blood. 2021 May 27;137(21):2881-2889
pubmed: 33735914
Ir J Med Sci. 2016 Nov;185(4):965-967
pubmed: 26358724
Medicine (Baltimore). 2022 Mar 04;101(9):e29013
pubmed: 35244080
Science. 2021 Dec 24;374(6575):eabl5450
pubmed: 34941394
Arch Oral Biol. 2016 Dec;72:75-86
pubmed: 27552374
Front Med (Lausanne). 2023 Jun 26;10:1055753
pubmed: 37435539
Blood. 2006 Nov 1;108(9):3021-6
pubmed: 16849641
Rheumatology (Oxford). 2004 Aug;43(8):1028-33
pubmed: 15161982
Int J Mol Med. 2014 Apr;33(4):763-8
pubmed: 24535478
J Periodontol. 1999 Aug;70(8):919-25
pubmed: 10476902
Front Immunol. 2019 Mar 29;10:665
pubmed: 30984205
Arch Dermatol Res. 2008 Jan;300(1):19-26
pubmed: 17960403
J Eur Acad Dermatol Venereol. 2008 Aug;22(8):950-7
pubmed: 18355201
J Clin Periodontol. 2023 Mar;50(3):295-306
pubmed: 36415901
Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii101-iii107
pubmed: 32348523
J Periodontol. 2007 Jun;78(6):1164-75
pubmed: 17539733
BMC Oral Health. 2015 May 14;15:59
pubmed: 25971786